600488 津药药业
已收盘 04-08 15:00:00
资讯
新帖
简况
多只创新药概念股涨停，津药药业回应七连板：“炒作”系误读
新京报 · 04-08 17:18
多只创新药概念股涨停，津药药业回应七连板：“炒作”系误读
津药药业(600488.SH)：目前公司甾体激素原料药价格总体保持平稳 对公司经营业绩无影响
智通财经网 · 04-07 20:27
津药药业(600488.SH)：目前公司甾体激素原料药价格总体保持平稳 对公司经营业绩无影响
津药药业（600488）披露股票交易异常波动公告，4月7日股价上涨10.04%
证券之星 · 04-07 17:07
津药药业（600488）披露股票交易异常波动公告，4月7日股价上涨10.04%
每周股票复盘：津药药业（600488）周内5次登龙虎榜
证券之星 · 04-05
每周股票复盘：津药药业（600488）周内5次登龙虎榜
津药药业最新公告：股价连续涨停提示风险
证券之星 · 04-03
津药药业最新公告：股价连续涨停提示风险
6连板！600488，直线涨停！创新药，异动！
e公司 · 04-03
6连板！600488，直线涨停！创新药，异动！
公告精选︱松霖科技：一季度净利润预增100.20%到141.99%；津药药业：目前研发以仿制药为主，无在研创新药项目
格隆汇 · 04-02
公告精选︱松霖科技：一季度净利润预增100.20%到141.99%；津药药业：目前研发以仿制药为主，无在研创新药项目
智飞生物修订与默沙东协议 “五连板”津药药业称无在研创新药
财闻 · 04-02
智飞生物修订与默沙东协议 “五连板”津药药业称无在研创新药
5连板津药药业：目前研发以仿制药为主无在研创新药项目
证券之星 · 04-02
5连板津药药业：目前研发以仿制药为主无在研创新药项目
津药药业(600488.SH)子公司收到药品GMP符合性检查结果
智通财经 · 04-02
津药药业(600488.SH)子公司收到药品GMP符合性检查结果
BD+业绩双重炸裂，创新药多股涨停，黄金窗口期来了？
格隆汇 · 04-02
BD+业绩双重炸裂，创新药多股涨停，黄金窗口期来了？
津药药业最新公告：股票交易异常波动及风险提示
证券之星 · 04-01
津药药业最新公告：股票交易异常波动及风险提示
4月1日津药药业（600488）龙虎榜数据
证券之星 · 04-01
4月1日津药药业（600488）龙虎榜数据
异动快报：津药药业（600488）3月30日9点39分触及涨停板
证券之星 · 03-30
异动快报：津药药业（600488）3月30日9点39分触及涨停板
每周股票复盘：津药药业（600488）组织机构调整不影响生产经营
证券之星 · 03-29
每周股票复盘：津药药业（600488）组织机构调整不影响生产经营
异动快报：津药药业（600488）3月27日10点19分触及涨停板
证券之星 · 03-27
异动快报：津药药业（600488）3月27日10点19分触及涨停板
津药药业（600488）披露公司组织机构调整公告，3月24日股价上涨4.85%
证券之星 · 03-24
津药药业（600488）披露公司组织机构调整公告，3月24日股价上涨4.85%
每周股票复盘：津药药业（600488）变更2025年度签字注册会计师
证券之星 · 03-22
每周股票复盘：津药药业（600488）变更2025年度签字注册会计师
津药药业（600488）披露关于变更签字注册会计师的公告，3月20日股价下跌2.91%
证券之星 · 03-20
津药药业（600488）披露关于变更签字注册会计师的公告，3月20日股价下跌2.91%
津药药业：截至2026年2月27日公司股东数为38344户
证券日报 · 03-03
津药药业：截至2026年2月27日公司股东数为38344户
加载更多
公司概况
公司名称：
津药药业股份有限公司
所属行业：
医药制造业
上市日期：
2001-06-18
主营业务：
津药药业股份有限公司的主营业务是甾体激素类、氨基酸类原料药及制剂的研发、生产和销售。公司的主要产品是甾体激素类、氨基酸类。公司是全球知名的甾体激素类药物生产企业和享誉全国的氨基酸原料药生产企业，国家高新技术企业，国内较早获得甾体激素类原料药GMP证书和天津市首批全部通过国家GMP认证的原料药及制剂生产企业。
发行价格：
11.25
{"stockData":{"symbol":"600488","market":"SH","secType":"STK","nameCN":"津药药业","latestPrice":7.36,"timestamp":1775631600000,"preClose":7.67,"halted":0,"volume":281439829,"delay":0,"changeRate":-0.0404,"floatShares":1092000000,"shares":1092000000,"eps":0.015,"marketStatus":"已收盘","change":-0.31,"latestTime":"04-08 15:00:00","open":8.36,"high":8.44,"low":7.13,"amount":2192000000,"amplitude":0.1708,"askPrice":7.36,"askSize":1484,"bidPrice":7.35,"bidSize":4167,"shortable":0,"etf":0,"ttmEps":0.015,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775698200000},"marketStatusCode":5,"adr":0,"adjPreClose":7.67,"symbolType":"stock","openAndCloseTimeList":[[1775611800000,1775619000000],[1775624400000,1775631600000]],"highLimit":8.44,"lowLimit":6.9,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1091886680,"isCdr":false,"pbRate":2.66,"roa":"--","peRate":490.666667,"roe":"2.25%","epsLYR":0.122,"committee":0.571277,"marketValue":8036000000,"turnoverRate":0.2578,"status":1,"floatMarketCap":8036000000},"requestUrl":"/m/hq/s/600488","defaultTab":"news","newsList":[{"id":"2625912888","title":"多只创新药概念股涨停，津药药业回应七连板：“炒作”系误读","url":"https://stock-news.laohu8.com/highlight/detail?id=2625912888","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625912888?lang=zh_cn&edition=full","pubTime":"2026-04-08 17:18","pubTimestamp":1775639880,"startTime":"0","endTime":"0","summary":"4月8日开盘，津药药业股价再度触及涨停后回落，截至收盘为7.36元/股。3月27日-4月7日，津药药业股价历经7连涨，区间累计涨幅94.67%。目前津药药业无创新药在研项目，却在近日被列为创新药概念在炒作，且最近一期业绩大幅下滑，津药药业已发布5次交易风险提示非理性炒作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-04-08/doc-inhtuqfz6560024.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-04-08/doc-inhtuqfz6560024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0102","BK1574","159992","06978","BK0028","600488","BK0012","BK0239","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625958683","title":"津药药业(600488.SH)：目前公司甾体激素原料药价格总体保持平稳 对公司经营业绩无影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2625958683","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625958683?lang=zh_cn&edition=full","pubTime":"2026-04-07 20:27","pubTimestamp":1775564873,"startTime":"0","endTime":"0","summary":"津药药业(600488.SH)发布股票交易严重异常波动暨风险提示公告称，公司关注到市场将公司列为创新药概念并进行炒作，公司目前研发以仿制药为主，无在研创新药项目，相关炒作存在明显误读。公司主营业务为甾体激素类、氨基酸类原料药及制剂的研发、生产和销售。同时，公司关注到市场对激素原料药产品价格的讨论，目前公司甾体激素原料药价格总体保持平稳，对公司经营业绩无影响。","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/7.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/7.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0012","BK0028","BK0102","600488","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625793636","title":"津药药业（600488）披露股票交易异常波动公告，4月7日股价上涨10.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625793636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625793636?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:07","pubTimestamp":1775552834,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，津药药业报收于7.67元，较前一交易日上涨10.04%，最新总市值为83.75亿元。该股当日开盘7.3元，最高7.67元，最低7.1元，成交额达13.23亿元，换手率为16.15%。公司于近日披露《津药药业股份有限公司股票交易异常波动公告》。公告显示，津药药业股票于2026年4月2日、4月3日连续两个交易日内日收盘价格涨幅偏离值累计达到20%，属于股票交易异常波动情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700023626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488","BK0102","BK0028","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625615238","title":"每周股票复盘：津药药业（600488）周内5次登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2625615238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625615238?lang=zh_cn&edition=full","pubTime":"2026-04-05 01:23","pubTimestamp":1775323389,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，津药药业报收于6.97元，较上周的4.33元上涨60.97%。本周，津药药业4月3日盘中最高价报6.97元，股价触及近一年最高点。本周关注点来自交易信息汇总：津药药业近5个交易日内4月3日前共5次登上龙虎榜。交易信息汇总津药药业于2026年3月30日至4月3日连续五个交易日累计五次登上龙虎榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0102","600488","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624656607","title":"津药药业最新公告：股价连续涨停提示风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2624656607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624656607?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:00","pubTimestamp":1775206810,"startTime":"0","endTime":"0","summary":"津药药业公告称，公司股票于4月2日、3日连续两个交易日内收盘价格涨幅偏离值累计达到20%，属于股票交易异常波动。公司提示，3月26日至4月3日期间股价连续六个交易日涨停，累计涨幅76.01%，市盈率显著高于行业平均水平，存在快速下跌风险。公司基本面未发生重大变化，2025年前三季度营收22.32亿元，同比下降13.24%；净利润6954万元，同比下降62.75%。经自查及向控股股东核实，公司及控股股东不存在应披露而未披露的重大事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300032810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0012","BK0239","600488","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624963182","title":"6连板！600488，直线涨停！创新药，异动！","url":"https://stock-news.laohu8.com/highlight/detail?id=2624963182","media":"e公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624963182?lang=zh_cn&edition=full","pubTime":"2026-04-03 10:14","pubTimestamp":1775182440,"startTime":"0","endTime":"0","summary":"4月3日，CPO概念、数字货币概念、运输服务、半导体、保险等板块涨幅居前；创新药概念、养殖业、供气供热、商业连锁等板块跌幅居前。 创新药部分走强，津药药业涨停走出6连板，6天累计涨幅近80%。 津药药业公告称，公司可能存在市场情绪过热、非理性炒作情况，公司基本面未发生重大变化，随时存在快速下跌的风险。截至4月2日，公司最新市盈率为424.82倍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/2026-04-03/doc-inhtetzf3800539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0102","BK1574","BK0028","06978","600488","159992","BK1161","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624032500","title":"公告精选︱松霖科技：一季度净利润预增100.20%到141.99%；津药药业：目前研发以仿制药为主，无在研创新药项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2624032500","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624032500?lang=zh_cn&edition=full","pubTime":"2026-04-02 23:11","pubTimestamp":1775142703,"startTime":"0","endTime":"0","summary":"宁波远洋：拟定增募资不超10.95亿元","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4290411","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["600488","603992","06978","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624047555","title":"智飞生物修订与默沙东协议 “五连板”津药药业称无在研创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2624047555","media":"财闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624047555?lang=zh_cn&edition=full","pubTime":"2026-04-02 21:20","pubTimestamp":1775136000,"startTime":"0","endTime":"0","summary":"默沙东授权公司按照协议约定，独家在中国大陆地区以默沙东商标进口、共同推广、经销和销售协议产品的权利。新协议不再约定协议产品的基础采购金额，公司与默沙东将根据市场预期需求和实际接种情况，协商确认预期采购与供应计划，公司据此滚动采购协议产品。本协议的签署深化了公司与默沙东的战略伙伴关系，有利于增强双方对市场变化的协同应对能力，减轻公司的经营压力并降低风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-04-02/doc-inhtcnfs0882895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2023250504.SGD","LU1037948897.HKD","LU0432979614.USD","LU2361044865.SGD","LU0006306889.USD","LU1116320901.HKD","LU2361045086.USD","LU0265550359.USD","LU2580892789.USD","LU1934455194.USD","LU2023250843.SGD","SG9999015358.SGD","LU0130102774.USD","LU1929549753.HKD","IE00B1BXHZ80.USD","LU1064131003.USD","SGXZ57979304.SGD","IE0002141913.USD","LU1069347547.HKD","LU0965509283.SGD","LU1989772840.SGD","BK4516","IE00BBT3K403.USD","LU0265550946.USD","LU1162221912.USD","LU1983299246.USD","BK0239","LU2361044949.HKD","LU1585245621.USD","BK1574","LU2461242641.AUD","SG9999002232.USD","LU1430594728.SGD","LU1917777945.USD","BK1161","LU0203347892.USD","LU1201861249.SGD","SG9999001176.USD","LU1093756325.SGD","LU0106261372.USD","LU2125154935.USD","LU0122379950.USD","BK4550","LU2148510915.USD","LU1989772923.USD","SG9999001440.SGD","IE00BFTCPJ56.SGD","BK0028","SG9999014575.USD","LU1023059063.AUD","IE00BLSP4239.USD","SG9999015341.SGD","LU1291159041.SGD","BK0012","LU0203345920.USD","LU0868494708.USD","LU0208291251.USD","LU2089984988.USD","LU0868494617.USD","LU1941712348.USD","LU1116320737.USD","LU1934455277.USD","LU1328615791.USD","LU2324357040.USD","BK0102","BK4534","LU0965508806.USD","SG9999014559.SGD","LU0942090050.USD","LU0648001328.SGD","LU0980610538.SGD","LU0477156953.USD","IE000M9KFDE8.USD","BK4533","600488","LU1066051811.HKD","LU0098860793.USD","BK0196","BK4588","IE00B4R5TH58.HKD","LU0070302665.USD","LU1699723380.USD","LU0965509010.AUD","LU2468319806.SGD","SG9999014567.USD","IE00B2B36J28.USD","LU1057294990.SGD","LU1571399168.USD","LU0238689110.USD","LU1093756168.USD","BK0046","IE00BJJMRZ35.SGD","LU2580892862.HKD","BK4585","LU1061106388.HKD","LU1934455863.HKD","LU0985320562.USD","SG9999001176.SGD","BK4007","LU1035773651.USD","LU2125154778.USD","LU0234572021.USD","LU1974910355.USD","IE00BLSP4452.SGD","LU0211331839.USD","BK4559","LU0320765646.SGD","LU1941712264.USD","LU2360032135.SGD","300122","IE00BJT1NW94.SGD","LU1066051498.USD","BK0188","SG9999014542.SGD","LU0130517989.USD","IE00BN8TJ469.HKD","SG9999013999.USD","LU1037948541.HKD","LU2106854487.HKD","IE00BSNM7G36.USD","LU0289739699.SGD","LU0320765489.SGD","LU0861579265.USD","LU0965509101.SGD","LU2112291526.USD","LU1989771016.USD","LU0058720904.USD","BK0077","SG9999002224.SGD","LU1066051225.USD","IE0009355771.USD","LU1064130708.USD","LU1066053197.SGD","LU0266013472.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624571064","title":"5连板津药药业：目前研发以仿制药为主无在研创新药项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2624571064","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624571064?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:38","pubTimestamp":1775119135,"startTime":"0","endTime":"0","summary":"津药药业(600488.SH)发布股票交易风险提示性公告称，公司关注到市场将公司列为创新药概念，公司目前研发以仿制药为主，无在研创新药项目。公司主营业务为甾体激素类、氨基酸类原料药及制剂的研发、生产和销售。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200027292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","BK0028","BK1574","600488","BK1161","BK0012","BK0239","06978","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624857984","title":"津药药业(600488.SH)子公司收到药品GMP符合性检查结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2624857984","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624857984?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:55","pubTimestamp":1775116503,"startTime":"0","endTime":"0","summary":"智通财经APP讯，津药药业(600488.SH)发布公告，近日，公司子公司湖北津药药业股份有限公司(简称“湖北津药”)收到湖北省药品监督管理局签发的《湖北省药品GMP符合性检查告知书》(编号：鄂GMP2026-90号)。检查范围：小容量注射剂/克林霉素磷酸酯注射液(国药准字H20065073)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0012","BK0102","BK0028","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624157850","title":"BD+业绩双重炸裂，创新药多股涨停，黄金窗口期来了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2624157850","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624157850?lang=zh_cn&edition=full","pubTime":"2026-04-02 14:03","pubTimestamp":1775109822,"startTime":"0","endTime":"0","summary":"进入收获期","market":"hk","thumbnail":"https://img3.gelonghui.com/a401d-e32ea773-2592-402d-a56d-8ff49dc1dd78.jpg?guru_height=718&guru_width=1280&guru_size=112216","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a401d-e32ea773-2592-402d-a56d-8ff49dc1dd78.jpg?guru_height=718&guru_width=1280&guru_size=112216"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4283048","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["159992","IAUM","MGCmain","PHYS","000788","OUNZ","BK4585","IAUI","SGCmain","GLTR","GDX","UGL","518880","JDST","DZZ","NUGT","XME","AAAU","JNUG","GDXU","02162","603222","IAU","SGOL","CEF","159831","QOmain","600594","1OZmain","300086","DUST","GDXY","DGP","159934","02186","GLD","BK1191","USG","PALL","GDXJ","GDXD","000950","600488","BTGD","GLDM","GCmain","GLL","06978","SGUmain","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624945915","title":"津药药业最新公告：股票交易异常波动及风险提示","url":"https://stock-news.laohu8.com/highlight/detail?id=2624945915","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624945915?lang=zh_cn&edition=full","pubTime":"2026-04-01 18:01","pubTimestamp":1775037675,"startTime":"0","endTime":"0","summary":"津药药业公告称，公司股票于3月31日、4月1日连续两个交易日收盘价格涨幅偏离值累计达20%，属于股票交易异常波动。公司提示，近期股价短期多次涨停，累计涨幅45.45%，市盈率显著高于行业水平，存在市场情绪过热及大幅下跌风险。经自查并函询控股股东，公司生产经营正常，不存在应披露而未披露的重大事项或处于筹划阶段的重大事项，董事及高管在异动期间无买卖公司股票行为。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100032973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488","BK0028","BK0012","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624120599","title":"4月1日津药药业（600488）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2624120599","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624120599?lang=zh_cn&edition=full","pubTime":"2026-04-01 17:20","pubTimestamp":1775035221,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年4月1日公布的交易公开信息显示，津药药业因非ST、*ST和S证券连续三个交易日内收盘价格涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第3次上榜。截至2026年4月1日收盘，津药药业报收于5.76元，上涨9.92%，换手率3.38%，成交量36.89万手，成交额2.12亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100031598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0028","600488","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623640263","title":"异动快报：津药药业（600488）3月30日9点39分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2623640263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623640263?lang=zh_cn&edition=full","pubTime":"2026-03-30 09:40","pubTimestamp":1774834848,"startTime":"0","endTime":"0","summary":"证券之星3月30日盘中消息，9点39分津药药业触及涨停板。其所属行业化学制药目前上涨。领涨股为东诚药业。该股为辅助生殖，化学原料药，医药概念热股，当日辅助生殖概念上涨1.21%，化学原料药概念上涨0.85%，医药概念上涨0.68%。3月27日的资金流向数据方面，主力资金净流入5444.26万元，占总成交额32.79%，游资资金净流出2720.21万元，占总成交额16.38%，散户资金净流出2724.05万元，占总成交额16.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000003949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","BK0012","600488","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623387720","title":"每周股票复盘：津药药业（600488）组织机构调整不影响生产经营","url":"https://stock-news.laohu8.com/highlight/detail?id=2623387720","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623387720?lang=zh_cn&edition=full","pubTime":"2026-03-29 01:39","pubTimestamp":1774719549,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，津药药业报收于4.33元，较上周的4.0元上涨8.25%。本周，津药药业3月27日盘中最高价报4.33元。3月23日盘中最低价报3.68元。津药药业当前最新总市值47.28亿元，在化学制药板块市值排名105/150，在两市A股市值排名3511/5191。本次调整不会对公司生产经营产生重大影响，不损害公司及股东利益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600488","BK0028","BK0012","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622681640","title":"异动快报：津药药业（600488）3月27日10点19分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2622681640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622681640?lang=zh_cn&edition=full","pubTime":"2026-03-27 10:25","pubTimestamp":1774578322,"startTime":"0","endTime":"0","summary":"证券之星3月27日盘中消息，10点19分津药药业触及涨停板。其所属行业化学制药目前上涨。领涨股为联环药业。该股为化学原料药，医药，辅助生殖概念热股，当日化学原料药概念上涨2.55%，医药概念上涨2.54%，辅助生殖概念上涨2.48%。3月26日的资金流向数据方面，主力资金净流出390.28万元，占总成交额13.17%，游资资金净流入33.6万元，占总成交额1.13%，散户资金净流入356.69万元，占总成交额12.03%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700017164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0012","600488","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621463095","title":"津药药业（600488）披露公司组织机构调整公告，3月24日股价上涨4.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621463095","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621463095?lang=zh_cn&edition=full","pubTime":"2026-03-24 22:47","pubTimestamp":1774363635,"startTime":"0","endTime":"0","summary":"截至2026年3月24日收盘，津药药业报收于3.89元，较前一交易日上涨4.85%，最新总市值为42.47亿元。该股当日开盘3.77元，最高3.89元，最低3.75元，成交额达3759.4万元，换手率为0.9%。公告显示，公司于2026年3月24日召开第九届董事会第二十五次会议，审议通过公司组织机构调整议案。本次调整不会对公司生产经营产生重大影响，不损害公司及股东利益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400040389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","600488","BK0012","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621799146","title":"每周股票复盘：津药药业（600488）变更2025年度签字注册会计师","url":"https://stock-news.laohu8.com/highlight/detail?id=2621799146","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621799146?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:04","pubTimestamp":1774119854,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，津药药业报收于4.0元，较上周的4.22元下跌5.21%。本周，津药药业3月16日盘中最高价报4.26元。津药药业当前最新总市值43.68亿元，在化学制药板块市值排名110/150，在两市A股市值排名3719/5190。本周关注点来自公司公告汇总：津药药业变更2025年度财务及内控审计签字注册会计师。张尧自2016年加入中审华，2022年5月成为中国注册会计师，近三年未签署或复核上市公司审计报告，未因执业行为受到处罚，符合独立性要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0012","BK0028","600488","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620784167","title":"津药药业（600488）披露关于变更签字注册会计师的公告，3月20日股价下跌2.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620784167","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620784167?lang=zh_cn&edition=full","pubTime":"2026-03-20 17:35","pubTimestamp":1773999352,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，津药药业报收于4.0元，较前一交易日下跌2.91%，最新总市值为43.68亿元。近日，津药药业股份有限公司发布公告称，因原签字注册会计师李媛辞职，中审华会计师事务所指派张尧接任公司2025年度财务审计和内控审计项目的签字注册会计师。张尧自2016年加入中审华，2022年5月成为中国注册会计师，近三年未签署或复核上市公司审计报告，未因执业行为受到处罚，符合独立性要求。本次变更不会对公司2025年度审计工作产生不利影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000030788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0012","600488","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616687328","title":"津药药业：截至2026年2月27日公司股东数为38344户","url":"https://stock-news.laohu8.com/highlight/detail?id=2616687328","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616687328?lang=zh_cn&edition=full","pubTime":"2026-03-03 20:39","pubTimestamp":1772541540,"startTime":"0","endTime":"0","summary":"证券日报网讯 3月3日，津药药业在互动平台回答投资者提问时表示，截至2026年2月27日，公司股东数为38344户。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-03/doc-inhptkrh7463912.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-03/doc-inhptkrh7463912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK0239","BK0102","600488","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775679613626,"stockEarnings":[{"period":"1week","weight":0.2778},{"period":"1month","weight":0.7608},{"period":"3month","weight":0.7778},{"period":"6month","weight":0.7821},{"period":"1year","weight":0.9606},{"period":"ytd","weight":0.7995}],"compareEarnings":[{"period":"1week","weight":0.0118},{"period":"1month","weight":-0.0248},{"period":"3month","weight":-0.0215},{"period":"6month","weight":0.0251},{"period":"1year","weight":0.27},{"period":"ytd","weight":0.0066}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"津药药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38307人(较上一季度增加0.59%)","perCapita":"28503股","listingDate":"2001-06-18","address":"天津市东丽区开发区西区新业九街19号","registeredCapital":"109188万元","survey":" 津药药业股份有限公司的主营业务是甾体激素类、氨基酸类原料药及制剂的研发、生产和销售。公司的主要产品是甾体激素类、氨基酸类。公司是全球知名的甾体激素类药物生产企业和享誉全国的氨基酸原料药生产企业，国家高新技术企业，国内较早获得甾体激素类原料药GMP证书和天津市首批全部通过国家GMP认证的原料药及制剂生产企业。","listedPrice":11.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"津药药业(600488)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供津药药业(600488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"津药药业,600488,津药药业股票,津药药业股票老虎,津药药业股票老虎国际,津药药业行情,津药药业股票行情,津药药业股价,津药药业股市,津药药业股票价格,津药药业股票交易,津药药业股票购买,津药药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"津药药业(600488)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供津药药业(600488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}